International Study of Biofield Therapy

MOA Health Science Foundation12,000 enrolled

Overview

Participants from 14 different countries received a single session of biofield therapy (Okada Purifying Therapy) lasting 30 minutes or longer from the volunteer practitioners. Before and after the therapy, they reported the severity of physical pain, anxiety/depression, dizziness/palpitation, and overall symptoms. The team compared the effectiveness/safety of biofield therapy between countries and analyzed the factors associated with the outcomes.

Participants aged 16 or older from 14 different countries (Japan, USA, Argentina, Brazil, Chile, Mexico, Peru, Taiwan, Thai, South Korea, Belgium, France, Portugal, and Spain) received a single session of biofield therapy (Okada Purifying Therapy) lasting 30 minutes or longer from the volunteer practitioners in their country of residence. Before and after the intervention, they reported each severity level of physical pain, anxiety/depression, dizziness/palpitation, and overall symptoms. The team compared the improvement/exacerbation rate of a single session of biofield therapy between the countries, and examined the adjusted odds ratio of the variables associated with the changes in each category of symptoms in a real-world setting.

Study Type

OBSERVATIONAL

Enrollment

12,000

Conditions

Pain Depression, Anxiety Dizziness Signs and Symptoms

Interventions

Okada Purifying TherapyOTHER

The practitioner raises his/her hand forward towards the recipient with the palm directed toward the recipient. The practitioner uses his/her hands alternately during the administration of Okada Purifying Therapy. The distance between the palm and the body is usually 1-2 feet, with each session typically lasting 30 to 60 minutes.

Eligibility

Sex: ALLMin age: 16 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. Individuals who agreed to receive a single session of biofield therapy for 30 minutes or longer from the volunteer investigators. 2. Individuals who were able to self-evaluate the change of their symptoms. 3. Individuals who were competent to answer the questionnaires. 4. Individuals who were aged 16 or older. Exclusion Criteria: * no specific exclusion criteria

Outcomes

Primary Outcomes

improvement/exacerbation rate of symptoms after a single session of biofield therapy

The Mann-Whitney test was conducted to compare the improvement/exacerbation rates between countries.

Time frame: Up to one year after all the data were collected.

adjusted odds ratio of the factors associated with the changes in symptoms

Logistic regression analyses

Time frame: Up to one year after all the data were collected.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.